News Detail
Amsterdam, 13 July 2024: Healthcare professionals in the European Union are to be issued with advice about the risk for anaphylactic reactions in patients with multiple sclerosis (MS......
View Details
Source : Medscape
multiple sclerosis; multiple sclerosis; MS
MS - multiple sclerosis
anaphylaxis
anaphylactic shock
glatiramer acetate
biologic therapy
biologics
Europe
European
adverse effects
side effects
anxiety
arthralgia
painful joint
joint pain
caregiver
disease modifying therapy
DMT - disease modifying therapy
Germany; German
medical literature
textbooks
multiple sclerosis relapse
MS relapse
Related News
- Critical medicines for cancer, diabetes set to get expensive as govt clears price hike, say sources (27-03-2025)
- DGFT proposes mandatory GST E-Invoices for pharma export benefits (27-03-2025)
- US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome (27-03-2025)
- FDA approves GSK’s 'Blujepa' for uncomplicated UTIs (27-03-2025)
- Bengal drug control publishes helpline to report fake medicines (27-03-2025)
- Misleading ads: SC asks states UTs to set up grievance redressal mechanism (26-03-2025)
- WHO partners with regulators, experts to strengthen safety and access of medical devices (26-03-2025)
- PCI warns of tough action against inspectors who don't follow its guidelines during inspection (26-03-2025)
- Seizure of fake Human Albumin Vials rings alarm bells (26-03-2025)
- Pharmacy owner, three others held for illegal sale of intoxication drug (26-03-2025)